Khalid El Sayed earned his BS in Pharmacy (1983), MS (1989) and PhD (1993) in natural products chemistry/pharmacognosy from Mansoura University, Egypt. His postdoctoral training was on marine natural products at the University of Mississippi. He is a tenured Professor at the School of Basic Pharmaceutical and Toxicological Sciences, University of Louisiana at Monroe, Monroe, LA, USA. His group’s most important direction is the anticancer activity of olive phenolics, specifically S-(-)-oleocanthal, through targeting the c-MET/SMYD2 and estrogen-α receptor. Other active projects in his laboratory include natural product inhibitors for cancer recurrence and neuroendocrine prostate cancer, PCSK9-LDLR small molecule inhibitors, specifically the fermentation product pseurotin A, anti-prostate cancer marine natural products, including Red Sea marine invertebrate-derived cembranoids, tobacco cembranoids/IDO/angiogenesis, and CBD/IDO1.